Molecular mechanisms of transformation and leukemogenesis by BCR-ABL Dr. Rick van Etten, Boston, United States of America
- Biography
English - 2008-06-13 Topic: Chronic Myeloid Leukemia
Speaker Disclosure
SAB member & research support:
• AstraZeneca Pharmaceuticals
• Cephalon Oncology
• Deciphera Pharmaceuticals
USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.
- 
